Determine the effects of ERCP complications in patients receiving diclofenac suppository with patients receiving acetaminophen suppositories in patients with gallstones

Comparison of ERCP complications with Diclofenac suppository and Acetaminophen suppository patients with CBD stone

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014020616504N1

Enrollment

140

Registered

2014-03-02

Start date

2014-01-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonsteroidal anti-inflammatory drugs. Other nonsteroidal anti-inflammatory drugs

Interventions

Intervention 1: Intervention group: Diclofenac Suppository, Once before ERCP. Intervention 2: Control group: Acetaminophen Suppositories, Once before ERCP.

Treatment - Drugs

Intervention group: Diclofenac Suppository, Once before ERCP

Control group: Acetaminophen Suppositories, Once before ERCP

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The main inclusion criteria to study: the need for ERCP (Endoscopic Retrograde Cholangiopancreatography) due to gallstones. The main exclusion criteria from study: presence of coagulation disorders have already been diagnosed; Taking medications that may interfere with coagulation tests.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Bleeding rate. Timepoint: During ERCP and during 24 hours after ERCP. Method of measurement: Monitoring vital signs and clinical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Bagheri Hosseini

Imam Reza Hospital

Hadibagheri-h@yahoo.com+98 51 1840 3741

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026